04/03/2024 7:14 PM | Alleva Lawrence M (Reporting) Mersana Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2024 3:05 PM | Mersana Therapeutics (Filer)
| Form POS AM | |
02/28/2024 7:49 AM | Mersana Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/28/2024 7:43 AM | Mersana Therapeutics (Filer)
| Form POSASR | |
02/28/2024 6:07 AM | Mersana Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 7:56 PM | Mersana Therapeutics (Subject) Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
02/14/2024 7:43 PM | Mersana Therapeutics (Subject) SILVERARC CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G | |
|
02/14/2024 5:55 PM | Mersana Therapeutics (Subject) ORBIMED ADVISORS LLC (Filed by)
| Form SC 13G/A | |
02/14/2024 8:20 AM | Avoro Capital Advisors LLC (Filed by) Mersana Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024 6:22 AM | BALYASNY ASSET MANAGEMENT L.P. (Filed by) Mersana Therapeutics (Subject)
| Form SC 13G | |
01/22/2024 12:36 PM | Mersana Therapeutics (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/17/2024 4:16 PM | Bala Mohan (Reporting) Mersana Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 4:18 PM | DeSchuytner Brian (Reporting) Mersana Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 4:18 PM | Carvajal Alejandra (Reporting) Mersana Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 4:19 PM | Huber Martin H. Jr. (Reporting) Mersana Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 4:19 PM | Lowinger Timothy B (Reporting) Mersana Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 4:20 PM | Mandelia Ashish (Reporting) Mersana Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 4:21 PM | Mersana Therapeutics (Issuer) MISRA TUSHAR (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 4:21 PM | Mersana Therapeutics (Issuer) Protopapas Anna (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/16/2024 8:12 PM | Mersana Therapeutics (Subject) Protopapas Anna (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024 8:13 PM | DeSchuytner Brian (Reporting) Mersana Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024 8:13 PM | Lowinger Timothy B (Reporting) Mersana Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024 8:14 PM | Bala Mohan (Reporting) Mersana Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/12/2024 3:42 PM | Mersana Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/05/2024 7:06 AM | Mersana Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/04/2024 3:14 PM | Hege Kristen (Reporting) Mersana Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 3:15 PM | Alleva Lawrence M (Reporting) Mersana Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/07/2023 7:42 AM | Mersana Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/07/2023 6:18 AM | Mersana Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/31/2023 7:12 AM | Mersana Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/04/2023 3:26 PM | Mersana Therapeutics (Issuer) MOTT DAVID M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/04/2023 3:27 PM | Alleva Lawrence M (Reporting) Mersana Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/04/2023 3:29 PM | Hege Kristen (Reporting) Mersana Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/04/2023 3:30 PM | Dere Willard H (Reporting) Mersana Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/04/2023 3:31 PM | Huber Martin H. Jr. (Reporting) Mersana Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/12/2023 7:27 AM | Mersana Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/07/2023 4:59 PM | Carvajal Alejandra (Reporting) Mersana Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/07/2023 4:51 PM | DeSchuytner Brian (Reporting) Mersana Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/07/2023 4:53 PM | Mersana Therapeutics (Issuer) MISRA TUSHAR (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/07/2023 4:55 PM | Mandelia Ashish (Reporting) Mersana Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/07/2023 4:57 PM | Lowinger Timothy B (Reporting) Mersana Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Secret Bull Market Starts in This Unusual Sector (Ad) "We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come."
In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch. Click for my No. 1 investment, all free of charge, click here. |
09/07/2023 4:46 PM | Bala Mohan (Reporting) Mersana Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
09/06/2023 6:08 AM | Mersana Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/08/2023 7:53 AM | Mersana Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/08/2023 7:04 AM | Mersana Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/31/2023 12:55 PM | EcoR1 Capital, LLC (Reporting) Mersana Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
07/27/2023 4:11 PM | EcoR1 Capital, LLC (Filed by) Mersana Therapeutics (Subject)
| Form SC 13G | |
07/27/2023 6:32 AM | Mersana Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/06/2023 3:23 PM | Huber Martin H. Jr. (Reporting) Mersana Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/06/2023 3:24 PM | Alleva Lawrence M (Reporting) Mersana Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/06/2023 3:18 PM | Mersana Therapeutics (Issuer) MOTT DAVID M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 6:38 AM | Mersana Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/12/2023 3:15 PM | Mersana Therapeutics (Issuer) MOTT DAVID M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2023 3:16 PM | Huber Martin H. Jr. (Reporting) Mersana Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2023 3:17 PM | Hege Kristen (Reporting) Mersana Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2023 3:19 PM | Diaz Allene M. (Reporting) Mersana Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/09/2023 7:55 AM | Mersana Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/09/2023 6:11 AM | Mersana Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/28/2023 5:00 AM | Mersana Therapeutics (Filer)
| Form DEF 14A | |
04/28/2023 5:02 AM | Mersana Therapeutics (Filer)
| Form DEFA14A | |
04/28/2023 5:04 AM | Mersana Therapeutics (Filer)
| Form ARS | |